Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy
Publication
, Journal Article
Eldar-Lissai, A; Cosler, L; Lyman, GH
Published in: Journal of Supportive Oncology
2005
Duke Scholars
Published In
Journal of Supportive Oncology
Publication Date
2005
Volume
3
Issue
2 SUPPL. 1
Start / End Page
54 / 55
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Eldar-Lissai, A., Cosler, L., & Lyman, G. H. (2005). Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy. Journal of Supportive Oncology, 3(2 SUPPL. 1), 54–55.
Eldar-Lissai, A., L. Cosler, and G. H. Lyman. “Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy.” Journal of Supportive Oncology 3, no. 2 SUPPL. 1 (2005): 54–55.
Eldar-Lissai A, Cosler L, Lyman GH. Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy. Journal of Supportive Oncology. 2005;3(2 SUPPL. 1):54–5.
Eldar-Lissai, A., et al. “Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy.” Journal of Supportive Oncology, vol. 3, no. 2 SUPPL. 1, 2005, pp. 54–55.
Eldar-Lissai A, Cosler L, Lyman GH. Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy. Journal of Supportive Oncology. 2005;3(2 SUPPL. 1):54–55.
Published In
Journal of Supportive Oncology
Publication Date
2005
Volume
3
Issue
2 SUPPL. 1
Start / End Page
54 / 55
Related Subject Headings
- Oncology & Carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis